A significant discovery in cancer study is occurring with the use of mini-antibodies to re-engage dysfunctional p53. This vital cancer suppressor protein is frequently disabled in many types of malignancies, resulting https://1001bookmarks.com/story21798166/nanobodies-reactivate-tumor-suppressor-p53-the-new-approach-for-tumor-treatment